bergen saratoga partnership housing development fund company, inc.

242 west 36th street
3rd floor
new york, new york 10018

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 23, 2014

NYS DOS ID#
4566055

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2014 - BERGEN SARATOGA PARTNERSHIP HOUSING DEVELOPMENT FUND COMPANY, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Greater Minnesota Housing Fund Launches Impact Investment Fund
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Thursday Jun 8, 2017

    A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....

    Source: Philanthropy News Digest (PND)
  • Trump Family Wedding Planner to Head New York’s Federal Housing Office
    By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017

    The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.

    Source: NYT > Home Page
  • ‘I’d Be Hurt and Upset’: Cities Fear Trump’s Cuts to Urban Programs
    By YAMICHE ALCINDOR - Friday Mar 17, 2017

    President Trump’s proposed cuts to the Department of Housing and Urban Development would eliminate programs cities have used to fund things like Meals on Wheels.

    Source: New York Times
  • Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
    By Frank Vinluan - Tuesday May 30, 2017

    Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]

    Source: Xconomy New York
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • Charter Urges Judge To Throw Out NY's Suit Over Slow Web Connections
    Tuesday Jun 20, 2017

    Cable company Charter is asking a judge to dismiss a lawsuit by New York Attorney General Eric Schneiderman, who alleges that the company duped consumers by delivering slower-than-advertised broadbandspeeds.

    Source: Media Post: Television News Daily
  • ‘I Have Stopped Taking My Notebooks and Pens to Meetings’
    By LELA MOORE and JULIA SIMON - Saturday Jun 17, 2017

    Our Top 10 Comments of the Week: Readers debate being interrupted at work, the shooting of a politician and the fate of American “Dreamers.”

    Source: NYT > Home Page